Literature DB >> 2137771

Second messengers of insulin action.

A R Saltiel1.   

Abstract

Despite significant advances in past years on the chemistry and biology of insulin and its receptor, the molecular events that couple the insulin-receptor interaction to the regulation of cellular metabolism remain uncertain. Progress in this area has been complicated by the pleiotropic nature of the actions of insulin. These most likely involve a complex network of pathways resulting in the coordination of mechanistically distinct cellular effects. Because the well-recognized mechanisms of signal transduction (i.e., cyclic nucleotides, ion channels) appear not to be central to insulin action, investigators have searched for a novel second-messenger system. A low-molecular-weight substance has been identified that mimics certain actions of insulin on metabolic enzymes. This substance has an inositol glycan structure, and is produced by the insulin-sensitive hydrolysis of a glycosylphosphatidylinositol in the plasma membrane. This hydrolysis reaction, which is catalyzed by a specific phospholipase C, also results in the production of a structurally distinct diacylglycerol that may selectively regulate one or more of the protein kinases C. The glycosyl-phosphatidylinositol precursor for the inositol glycan enzyme modulator is structurally analogous to the recently described glycosyl-phosphatidylinositol membrane protein anchor. Preliminary studies suggest that a subset of proteins anchored in this fashion may be released from cells by a similar insulin-sensitive phospholipase-catalyzed reaction. Future efforts will focus on the precise role of the metabolism of glycosyl phosphatidylinositols in insulin action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137771     DOI: 10.2337/diacare.13.3.244

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  30 in total

1.  Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.

Authors:  Kai I Cheang; Jean-Patrice Baillargeon; Paulina A Essah; Richard E Ostlund; Teimuraz Apridonize; Leila Islam; John E Nestler
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

2.  Signalling pathways of an insulin-mimetic phosphoinositolglycan-peptide in muscle and adipose tissue.

Authors:  A Kessler; G Müller; S Wied; A Crecelius; J Eckel
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 3.  Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.

Authors:  Julie Brown; Tineke J Crawford; Jane Alsweiler; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2016-09-07

Review 4.  Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus.

Authors:  Claudio Celentano; Barbara Matarrelli; Peter A Mattei; Giulia Pavone; Ester Vitacolonna; Marco Liberati
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

5.  Molecular effects of sulphonylurea agents in circulating lymphocytes of patients with non-insulin-dependent diabetes mellitus.

Authors:  I Rabbone; M Piccinini; M Curto; M Mostert; S Gamba; S Mioletti; R Bruno; M T Rinaudo
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

6.  D-chiro-inositol metabolism in diabetes mellitus.

Authors:  R E Ostlund; J B McGill; I Herskowitz; D M Kipnis; J V Santiago; W R Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study.

Authors:  Chika Ifeanyi Chukwuma; Mohammed Auwal Ibrahim; Md Shahidul Islam
Journal:  J Physiol Biochem       Date:  2016-09-06       Impact factor: 4.158

8.  A phosphatidylinositol-linkage-deficient T-cell mutant contains insulin-sensitive glycosyl-phosphatidylinositol.

Authors:  M A Avila; R Clemente; I Varela-Nieto
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

9.  Effects of acute pinitol supplementation on plasma pinitol concentration, whole body glucose tolerance, and activation of the skeletal muscle insulin receptor in older humans.

Authors:  A J Stull; K V Wood; J P Thyfault; W W Campbell
Journal:  Horm Metab Res       Date:  2009-02-16       Impact factor: 2.936

10.  Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans.

Authors:  G Müller; S Wied; C Piossek; A Bauer; J Bauer; W Frick
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.